Gun Ei Chemical Industry (4229) FY2026 Q3 Earnings Report

Quick View

Executive Summary

Cumulative Q3 results recorded increases in both revenue and earnings, with the key feature being an improvement in profitability, as growth in Operating Income significantly outpaced revenue growth. Revenue was ¥23.52B (+3.6% YoY), Operating Income was ¥2.23B (+31.4%), Ordinary Income was ¥2.49B (+25.6%), and Net Income was ¥1.86B. The Operating Margin improved to 9.5% from approximately 7.5% in the same period of the previous year, indicating that control of SG&A expenses and margin expansion are driving earnings growth beyond the increase in revenue.

Factors Affecting Results

【Revenue】Revenue was ¥23.52B, representing a moderate 3.6% increase YoY. By segment, Chemicals was the core business, generating ¥19.89B and accounting for approximately 84.6% of total revenue, together with Operating Income of ¥2.04B and a 10.2% margin. Grocery generated ¥3.45B and has meaningful scale, but its margin remained at 2.1%. RealEstateUtilization was small at ¥0.19B, but its margin was exceptionally high at 63.8%.

【Profit and Loss】Operating Income was ¥2.23B (+31.4% YoY), significantly exceeding revenue growth, with operating leverage emerging from a structure consisting of a 23.5% gross margin and a 14.1% SG&A ratio. Ordinary Income was ¥2.49B, including ¥0.30B in non-operating income, primarily consisting of ¥0.17B in dividend income and ¥0.08B in interest income. The ¥0.05B extraordinary loss, consisting of losses on disposal of fixed assets, was a temporary factor with a limited impact. Net Income of ¥1.86B represents the level after deducting the tax burden from Ordinary Income and is classified as an increase in both revenue and earnings.

Segment Analysis

The Chemicals segment serves as the core of overall performance, with revenue of ¥19.89B, representing 84.6% of total revenue, and Operating Income of ¥2.04B. Grocery generated ¥3.45B in revenue and ¥0.07B in Operating Income, with a margin of 2.1%, making its contribution to profitability limited. RealEstateUtilization was small at ¥0.19B in revenue, but its margin was exceptionally high at 63.8%, supporting the overall margin. The business portfolio as a whole is structured such that the performance of Chemicals determines overall results.

Key Financial Metrics

【Profitability】The Operating Margin of 9.5% and Net Profit Margin of 7.2% (Net Income ÷ Revenue) improved from the levels of the same period of the previous year, confirming margin expansion within a structure consisting of a 23.5% gross margin and a 14.1% SG&A ratio.【Cash Flow Quality】Comprehensive Income of ¥3.98B significantly exceeded Net Income attributable to owners of the parent of ¥1.69B, primarily due to ¥2.25B in valuation difference on securities, indicating a substantial contribution from valuation gains and losses separate from business earnings.【Investment Efficiency】ROE was 3.4%, while total asset turnover remained approximately 0.36x. The asset composition, including ¥14.29B in investment securities, equivalent to 21.9% of total assets, is suppressing capital efficiency.【Financial Soundness】The Equity Ratio was 84.3%. With current assets of ¥24.90B compared with current liabilities of ¥6.29B, liquidity was extremely high, reflecting a conservative capital structure with low financial leverage.

Cash Flow Analysis

Although the cash flow statement has not been disclosed, funding trends can be inferred from changes in the balance sheet. Cash and deposits were ¥9.04B, a slight decrease from ¥9.25B in the same period of the previous year. Meanwhile, investment securities have been increasing from ¥14.29B, and construction in progress also amounted to ¥3.95B, indicating the accumulation of investments in tangible fixed assets. Retained earnings increased to ¥21.67B from ¥20.64B in the same period of the previous year, reflecting progress in the retention of current-period earnings. Overall, the allocation of funds appears to involve continuing capital investment and securities holdings while maintaining substantial liquidity on hand.

Earnings Quality

The difference between Ordinary Income and Net Income is attributable to income taxes and the portion attributable to non-controlling interests, while the impact of extraordinary gains and losses was limited. Extraordinary income of ¥0.004B was outweighed by an extraordinary loss of ¥0.045B, primarily consisting of losses on disposal of fixed assets; both were small, temporary factors. Of the ¥0.30B in non-operating income, ¥0.17B in dividend income and ¥0.08B in interest income represent recurring income from held financial assets and support Ordinary Income as sources of non-business income. Comprehensive Income of ¥3.98B significantly exceeded Net Income, primarily due to ¥2.25B in valuation difference on securities. Accordingly, it should be noted that the earnings structure is subject to fluctuations arising from market movements separately from the earning power of the core business.

Earnings Forecast and Guidance

The full-year forecast calls for Revenue of ¥31.00B (+1.5% YoY), Operating Income of ¥2.30B (+0.3%), and Ordinary Income of ¥2.50B (-8.0%). The cumulative Q3 progress rates are 75.9% for Revenue, 96.8% for Operating Income, 99.4% for Ordinary Income, and 99.6% for Net Income, indicating that the earnings items have nearly reached their full-year forecasts. Assuming the forecasts remain unchanged, Q4 Operating Income would decline sharply to approximately ¥0.07B, making it important to determine whether the unchanged full-year plan is conservative or incorporates temporary earnings-decline factors in the second half.

Shareholder Returns

The Q2 dividend was ¥50.00 per share, and the full-year dividend forecast is ¥100.00 per share. Based on the full-year Net Income forecast of ¥1.70B and the number of shares outstanding after deducting treasury shares, the Payout Ratio is estimated to be in the 50% range, which is not excessively burdensome. The company holds ¥6.21B in treasury shares, equivalent to approximately 26% of shares outstanding. However, as the presence or absence of additional repurchases during the current period cannot be confirmed from the disclosed information, the assessment here is based solely on dividends.

Risk Factors

1. Raw Material and Energy Cost Volatility Risk: With the Chemicals segment accounting for 84.6% of revenue, fluctuations in raw material prices and delays in passing costs through to selling prices could undermine the improvement in the Operating Margin to 9.5% achieved during the current period.

2. Capital Efficiency Challenge: ROE was 3.4%, while total asset turnover remained low. The asset composition, including ¥14.29B in investment securities, equivalent to 21.9% of total assets, is suppressing capital efficiency. It should also be noted that market fluctuations affect net assets through valuation difference on securities.

3. Second-Half Profitability Under the Full-Year Plan: While cumulative Operating Income progress has reached 96.8%, assuming the full-year forecast remains unchanged implies a sharp decline in the Q4 margin. The actual performance trend in the second half therefore requires monitoring.

Industry Benchmark (Reference; Company Analysis)

Industry Benchmark (manufacturing)

Profitability and Returns

The company's profitability is above the industry median.

Growth and Capital Efficiency

The revenue growth rate is approximately in line with the industry median and falls within the IQR range.

※Source: Company analysis

Key Earnings Highlights

1. The expansion of the Operating Margin from approximately 7.5% in the same period of the previous year to 9.5%, resulting in earnings growth exceeding revenue growth, is notable as evidence of progress in improving the cost structure.

2. The progress rate against the full-year earnings plan is extremely high at over 96%, making the way in which the sharp decline in the margin expected in Q4 appears in the actual results a key focus of the earnings data.

3. An Equity Ratio of 84.3% and a financial structure in which current assets substantially exceed current liabilities indicate a conservative financial position. At the same time, the weighting of assets allocated to investment securities is affecting the capital efficiency metric, ROE of 3.4%.

Theoretical Share Price (Reference Value)

Sensitivity: ¥6,675–¥7,058 at ±1% for the Cost of Equity, and ¥6,816–¥6,892 at ±0.1 for ω.

Notes:

• Because the progress of Net Income against the full-year forecast is 100%, exceeding the standard 75%, forecast EPS has been adjusted upward within a maximum range of +10% (because companies with progress ahead of schedule tend to exceed forecasts. For businesses with strong seasonality, the adjustment may be excessive).
• Because forecast ROE is below the Cost of Equity, the theoretical value is below Book Value per Share.
• Net assets as of the end of the quarter are used; there is a time gap between these and the full-year forecast.
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat above the appropriate level.

(Calculation model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated solely from publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee the future share price)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, consulting a professional as necessary.

---End of Report---